Introduction
============

As women have commonly begun opting to establish their careers before they begin having children, efforts to conceive are increasingly being postponed to later reproductive ages. Thus growing numbers of women are using ART when they are not otherwise able to conceive. Ovarian cysts are found in around 7% of premenopausal women [@R7676722-6] during routine screening transvaginal ultrasound.

When ovarian cysts persist, they are usually not due to cyclic changes and therefore tend not to regress. Such cysts include endometrioma, dermoid, and serous or mucinous cystadenomas.

They can affect ovarian stimulation and sometimes they grow during controlled ovarian stimulation. As ART in Germany needs a financial support from the concerned couples, initial conditions before treatment should be optimal.

Due to the risks ovarian cysts present, potential rupture or malignancy, laparoscopic cystectomy has become the gold standard in the surgical management of persistent adnexal masses [@R7676722-1] ,  [@R7676722-7] . Thus, ovarian cystectomy affects ovarian reserves [@R7676722-17] ,  [@R7676722-23] and consequently ART outcomes [@R7676722-5] ,  [@R7676722-29] .

Therefore a surgical approach is not always the first choice. The IOTA criteria described by Timmerman [@R7676722-26] give good features to evaluate the dignity of an ovarian mass. The practicability was proofed and described in a metaanalysis by Nunes [@R7676722-15] .

To date, most published studies on ovarian cysts only include endometriomas, meaning that other entities remain under-represented [@R7676722-25] . As their definitive histological type is not known at the time of diagnosis, IOTA criteria help us to determine how they are managed clinically.

This large sample study aimed to evaluate both options that patients and physicians have when persistent ovarian cysts are found before ART treatment. We purposed to analyze the impact of ovarian cyst removal versus conservative management on patients considering IVF/ICSI procedures. Using a notable control group, we tried to evaluate the impact of the cyst itself, regardless of histological type. We are specifically interested in understanding fertility consequences of ovarian surgical procedures.

Material and Methods
====================

Patients
--------

This is a retrospective single center cohort study. Between 2002 and 2011 14 102 patients 18 to 40 years old underwent IVF/ICSI treatment at the fertility center Kinderwunschzentrum Wiesbaden because of female, idiopathic or male subfertility.

At the beginning of the ovarian cycle a vaginal ultrasound was performed. 13 552 patients did not present any pathological finding during transvaginal ultrasound (control group). 550 patients were diagnosed with a persistent asymptomatic ovarian cyst. These ovarian masses were unsuspecting lesions according to IOTA criteria, and were 20 -- 50 mm. After medical examination and counseling 328 patients personally decided to undergo a conventional laparoscopic cyst extirpation (group 1), 222 patients decided not to undergo any surgery (group 2).

We analyzed the first IVF/ICSI cycle. Several parameters were documented including age, total gonadotrophin stimulation dose, stimulation time, mean number of oocytes retrieved (MNOR), fertilization rate (FR), clinical pregnancy rate (CPR). The pregnancy outcome was analyzed by the live birth rate (LBR) and miscarriage rate (MR).

Treatment
---------

Women underwent either long agonist protocol or GnRH antagonist protocol controlled ovarian hyperstimulation. The long agonist protocol included initial down regulation with GnRH agonist as a depot injection during the mid-luteal phase of the previous menstrual cycle. The GnRH antagonist was initiated when the lead follicle had a diameter of 12 -- 14 mm, usually on the 6th day of stimulation and was given daily. Recombinant FSH was started from day 2 or 3 of the cycle and dosages were calculated based on patientsʼ age, antral follicle count (AFC), basal FSH/LH levels, and response to previous ovarian stimulation. The individual daily dose was adjusted based on follicular growth monitoring and estradiol levels in order to achieve optimal ovarian response in all patients. 10 000 IU hCG were administered subcutaneously when at least two follicles had a diameter of over 18 mm. Oocyte retrieval was performed 36 hours later.

Standard laboratory protocols were followed, including intracytoplasmic sperm injection. All assisted reproductive techniques were used according to the "Deutsches Embryonenschutzgesetz" (embryo protection law). Ultrasound guided transfer of one, two or, at most, three embryos was performed on day three after oocyte retrieval. All patients received a progesterone supplement during the luteal phase. Serum β-HCG level was measured fourteen days after the transfer. Pregnancy was diagnosed if serum β-HCG was at least 50 IU/ml and an ultrasound examination two weeks later confirmed the presence of a gestational sac in the uterine cavity. Phone follow-up was performed 40 weeks after embryo transfer in order to collect data about the obstetrical outcome.

Statistics
----------

Statistical analysis was performed through Statistics Package for Social Sciences (SPSS 22.0, Chicago IL, USA).

For the descriptive analysis categorical variables were summarized as total numbers and percentages and means with standard deviations where given for continuous variables.

Median with first and third quartiles (Q1 and Q3) were given for non-normally distributed continuous variables.

The association of the outcome variable of being pregnant or not was analyzed for different continuous variables like total FSH dosis, duration of treatment, MNOR and FR using a linear model.

For categorical variables like CPR, MR and LBR we performed logistic regression models and adjusted for age. The results of the models are presented as odds ratios (ORs) with 95% confidence intervals. The analyses were performed as explorative analyses. P-values were given for descriptive reasons only, and should be interpreted in connection with the effect estimates (OR).

Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Results
=======

A total of 14 102 patients who had undergone an IVF/ICSI cycle between 2002 and 2011 were analyzed. 328 patients with a persistent mass decided to perform a laparoscopic cyst extirpation and 222 patients decided not to undergo any surgery. 13 552 control patients had no diagnosable ovarian cyst (see [Table 1](#TB7676722-1){ref-type="table"} and [Fig. 1](#FI7676722-1){ref-type="fig"} for further baseline characteristics).

###### 

**Table 1**  Results of the analysed linear regression models for age, FSH dosis, duration of treatment, mean number of oocytes retrieved (MNOR), fertilization rate (FR), clinical pregnancy rate (CPR) live birth rate (LBR) and miscarriage (MR). All models were adjusted for age.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                            Total            Group 1: ovarian cyst surgically treated   Group 2: intact ovarian cyst   Group 3: control group   p-value
  ----------------------------------------- ---------------- ------------------------------------------ ------------------------------ ------------------------ -----------------
  Age (years)                               33.1 ± 4.2       33.0 ± 4.3                                 34.3 ± 4.0                     33.1 ± 4.2               n. s.

  Total dose of FSH used (IU)               2217.4 ± 945.5   2375.6 ± 1159.5\*                          2576.4 ± 1269\*\*              2207.5 ± 931.9\*, \*\*   \* p = 0.001\
                                                                                                                                                                \*\* p \< 0.001

  Duration of treatment (days)              11.1 ± 3.4       11.3 ± 4.2                                 11.3 ± 3.5                     11.1 ± 3.4               n. s.

  Mean number of oocytes retrieved (MNOR)   9.5 ± 5.37       8.2 ± 5.0\*, \*\*                          9.0 ± 5.5\*\*                  9.5 ± 5.4\*              \* p = 0.00

                                                                                                                                                                \*\* p = 0.012

  Fertilization rate (FR %)                 62.1 ± 22.9      63 ± 23.7                                  60.6 ± 24.4                    62.1 ± 22.8              n. s.

  Pregnant women                            4796             110                                        57                             4629                     

  Clinical pregnancy (CPR %)                34%              (33.5%)\*                                  (25.7%)\*, \*\*                (34.2%)\*\*              \* p = 0.062\
                                                                                                                                                                \*\* p = 0.022

  Deliveries                                3057             60                                         30                             2967                     

  Live birth (LBR %)                        21.70%           18.30%                                     (13.5%)\*                      (21.9%)\*                \* p = 0.008

  Miscarriage (MR)                          1100 (22.9%)     29 (26.4%)                                 16 (28.1%)                     1065 (23.0%)             n. s.

  Unknown pregnancy outcome                 629 (4.5%)       21 (6.4%)                                  11 (5%)                        597 (4.4%)               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![ Results for FSH dosis, mean number of oocytes retrieved (MNOR), fertilization rate (FR), clinical pregnancy rate (CPR), live birth rate (LBR) and miscarriage (MR) in the three groups.](10-1055-a-0767-6722-i7676722gf01){#FI7676722-1}

Patients were on average 33.1 years old (± 4.2) and required a mean dose of 2217.4 IU (± 945.5) of recombinant FSH for 11.1 days (± 3.4). The mean number of oocytes retrieved was 9.5 (± 5.4) with a fertilization rate of 62.1% (± 22.9). Concerning oocyte quality, a fertilization rate of 62.1% (± 22.9) was found. The overall clinical pregnancy rate was 34% with a miscarriage rate of 22.9%. The overall live birth rate was 22.95%.

Age
---

All of the patients were comparable in terms of age. The mean age of patients who underwent ovarian cystectomy was 33 years (± 4.3), comparable to the mean age of those patients who did not undergo surgery (34 ± 4.0 years) and to that of the control group (33 ± 4.2 years).

Stimulation
-----------

Patients from all groups were stimulated with comparable gonadotrophin doses for a similar time frame.

Operated patients were stimulated for 11.3 days (± 4.2) and patients with an intact ovarian cyst were stimulated for 11.3 days (± 3.5). Control patients were stimulated for 11.1 days (± 3.4).

Both operated and non-operated patients with ovarian cysts (group 1 and 2) needed similar doses and required on average higher stimulation dose than the controls. Patients with an intact ovarian cyst required on average mean 113.96 IU (− 88.111 -- 316.039) few more doses of gonadotrophin than the patients who had undergone ovarian cyst removal procedures, without relevance (2576 ± 1269 vs. 2376 ± 1160 IU; p-value = 0.268).

Controls needed the lowest stimulation dose. They required on average mean 170.27 IU (− 270.79 -- − 69.76) relevant few less doses than the cystectomy group (2208 ± 932 vs. 2376 ± 1160 IU; p-value = 0.001) and relevant few less doses than the non operated group (2208 ± 932 vs. 2576 ± 1269 IU; p-value \< 0.001).

Oocyte retrieval
----------------

Concerning the mean number of oocytes retrieved (MNOR) there was a significant difference comparing both ovarian cyst groups (p-value = 0.012). MNOR was higher in the group who did not undergo surgery (9 ± 5.5 vs. 8.2 ± 5.0 oocytes). Compared to controls, the surgical group (group 1) showed significant lower amount of oocytes (9.5 ± 5.4 vs. 8.2 ± 5.0 oocytes; p-value = 0.00). Patients after cystectomy (group 1) showed the lowest MNOR. Patients with an intact ovarian cyst and controls showed similar MNOR (9 ± 5.5 vs. 9.5 ± 5.4 oocytes; p-value = 0.39).

Fertilization rate (FR)
-----------------------

Concerning oocyte quality, FR were similar in all groups, without statistical significance.

Clinical Pregnancy Rate (CPR)
-----------------------------

The intact ovarian cyst group (group 2) showed the lowest chances of achieving pregnancy. When comparing no surgery (group 2) with surgery (group 1) (25.7 vs. 33.5%) there was a reduction of 30.5% in the chance of achieving a pregnancy (OR 0.695 \[95% CI 0.474 -- 1.019\] p-value = 0.062). The surgical group (group 1) and the controls showed comparable CPR (33.5 and 34.2%, OR 1.031 \[95% CI 0.817 -- 1.302\] p-value = 0.795). Relevant higher CPR was observed in controls than in patients with an intact ovarian cyst (34.2 vs. 25.7%, OR 1.428 \[95% CI 1.054 -- 1.936\] p-value = 0.022).

Live birth rate (LBR)
---------------------

It was possible to collect follow-up data from 94.73% of the women who became pregnant. The number of live births in women with an operated ovarian cyst, intact cyst, and no cysts were similar: 60 (18.3%), 30 (13.5%), and 2967 (21.9%) respectively. Even though lower LBR in those who preferred conservative management (group 2) than after surgery was found, no statistical differences emerged (13.5 vs. 18.3%, OR 0.71 \[95% CI 0.439 -- 1.148\] p-value = 0.163). LBR on the controls was comparable to the cystectomy group (21.9 vs. 18.3%), OR 1.26 (95% CI 0.948 -- 1.674) p-value = 0.111. Nevertheless relevant higher LBR was found on the controls when compared to the intact ovarian cyst group (21.9 vs. 13.5%, OR 1.685 \[95% CI 1.143 -- 2.485\] p-value = 0.008).

Miscarriage rate (MR)
---------------------

There were no remarkable differences among the MR. The number of miscarriages in women with operated cysts, intact ovarian cysts, and no cysts were 29 (26.4%), 16 (28.1%), and 1065 (23%) respectively. No relationship was found when comparing miscarriages in the non-operated patients with operated patients (28.1 vs. 26.4%, OR 1.030 \[95% CI 0.499 -- 2.126\] p-value = 0.935) or in the controls with the operated patients (23 vs. 26.4%, OR 0.853 \[95% CI 0.554 -- 1.314\] p-value = 0.47). Likewise, no important differences were found when comparing MR in the controls with the intact ovarian cyst group, (23 vs. 28.1%, OR 0.826 \[95% CI 0.46 -- 1.482\] p-value = 0.521).

Discussion
==========

As women reproduction is systematically being postponed to later ages, there is a growing number of subfertile patients with less time left. Ovarian cysts are common discoveries in women of reproductive age, especially during ART treatment.

Their physicians are confronted with important fertility questions searching the most appropriate therapeutical strategy for them. While surgery allows a histological diagnostic helping to exclude possible malignant tumors, the ovarian reserve can be reduced after cystectomy, reducing fertility outcomes [@R7676722-17] ,  [@R7676722-19] ,  [@R7676722-23] . Furthermore, surgical procedures may critically delay the start of ART treatments in patients who are per se aware of their limited fertility, causing stress and anxiety. On the other hand, a conservative treatment with regular follow-ups, especially in asymptomatic cases is also possible. The IOTA criteria make it possible to characterize ovarian findings and to estimate the risk of malignancy. On the whole, physiciansʼ dilemma is not easy to solve because surgerysʼ long-term effect on fertility remains unclear.

How does the presence of ovarian cysts in our sample influence the pregnancy rate? The fertility impact of the cyst depends on its nature, size and number. Endometriomas account for around 35% of all the persistent benign cysts [@R7676722-28] . Histological analyzes after ovarian cystectomy included 47% endometriomas, 24% dermoid cysts, 16% serous cystadenomas and 13% mucinous cystadenomas [@R7676722-18] . Similar results were found on previous publications [@R7676722-10] . Therefore, we assume the rate of endometrial cysts present in our sample to be between 35 -- 45%. Cystadenomas are often discovered in women after their reproductive phase.

There is a relationship between endometriosis and infertility [@R7676722-11] . A recent literature review reported that its presence reduces the number of oocytes retrieved and fertilization rates in IVF therapies [@R7676722-21] . Legendre et al. pointed out that it is difficult to determine the influence of endometriomas and endometriosis on fertility [@R7676722-13] .

The presence of endometriomas smaller than 4 cm does not appear to influence the results of ART [@R7676722-2] ,  [@R7676722-3] ,  [@R7676722-14] ,  [@R7676722-27] ,  [@R7676722-30] . There is a general recommendation to treat only symptomatic endometriomas and/or unilateral endometriomas \> 4 cm [@R7676722-24] .

After surgery, AMH level was significantly lower [@R7676722-17] , showing a decline in ovarian reserve. The larger the size of endometrioma, the bigger the impact of surgery on the ovarian reserve [@R7676722-16] . The Cochrane meta-analysis by Benschop et al. [@R7676722-5] , focused on the management of endometriomas before IVF treatment and reported that surgery did not improve pregnancy rates. The number of oocytes was lower after cystectomy. Also a metaanalysis of Tsoumpou [@R7676722-29] and Garcia-Velasco [@R7676722-9] et al. could not find any benefit of surgery increasing clinical pregnancies.

There are only a few data to non endometriotic cysts. Dermoid cysts are the most common benign finding in the ovaries of young women during their fertility lifespan [@R7676722-12] . One of the studies reported six patients in their sample who had dermoid cysts (as diagnosed by transvaginal ultrasound) while undergoing IVF treatment. All of them achieved similar serum estrogens levels, oocyte retrieval numbers, and gave birth to healthy babies. Despite the small sample size, there is an implication that dermoid cysts do not irreparably affect fertility outcomes [@R7676722-7] . There is no clear recommendation concerning the extirpation of dermoid cysts prior to ART. The risk of dermoid torsion, rupture and malignancy increases with the dermoid size as well as the complexity of the procedure. In non endometriotic cysts, some studies found a postsurgical ovarian damage with decreased ovarian reserve up to 40% [@R7676722-8] ,  [@R7676722-22] .

In this retrospective study we focused on a cohort of 550 patients with an asymptomatic incidental ovarian finding before starting an IVF treatment. 328 decided to undergo surgery and 222 preferred a conservative management. Although the lower number of oocytes retrieved after surgery could suggest a negative quantitative effect on the ovary, surgery itself did not impair fertilization rate, pregnancy rate or live birth rate. Comparing this data with a heterogenous notably control group representing an average infertile patient undergoing IVF/ICSI treatment during the same period of time, similar pregnancy outcomes were found. We can postulate that surgery does not seem to worsen fertility outcomes as much as the presence of an ovarian cyst does. Our data confirms previous literature [@R7676722-9] .

Nevertheless it remains unclear why patients with a remaining cyst showed an apparently lower ovarian responsiveness to hyperstimulation, with higher dosis of gonadotrophin required to obtain the same amount of oocytes and why did they showed relevant lower pregnancy rate and live birth rate than controls. One possible explanation might be a concomitant chronic pelvic inflammation found in non-operated endometriomas inducing infertility and thereby confounding the results [@R7676722-4] .

Another explanation could be patientsʼ age, although the difference was not significant. The patients who did not undergo surgery were 1.2 to 1.3 years older than the controls. In an earlier publication [@R7676722-20] we showed that every year the probability of achieving pregnancy reduces 6%.

Some limitations of our study must be taken into consideration. As we did not gather the exact cyst size or histology, we are unable to determine the exact influence of endometriomas discussed above. Regarding the cyst size we assume size bias should bring smaller cysts not to be removed and to increase pregnancy rates, increasing the trend observed in this study. Other limitations are a well-known medical counseling bias and the retrospective cohort design. In order to minimize the confounding elements, we decided to enlarge the cohort. While this did improve our data set, this innacurate control group includes patients with other infertility issues that might affect the results. In our opinion, the control group should represent an average infertile patient attending a fertility center and we do not generate general recommendations.

Conclusion
==========

There are many aspects involved on fertility patients when ovarian cysts are found, making it difficult to determine the exact impact of ovarian surgery. Counseling physicians rely on guidelines, such as the IOTA criteria, making it possible to estimate the risk of malignancy. Statistics show that endometriomas are the most frequent ovarian masses in patients in their reproductive phase. Presented literature gives no hint if any surgery leads to an improvement on the pregnancy rates. This retrospective analysis together with the current literature might help patientsʼ and physicians decision when ovarian cysts are present before ART procedures.

In symptomatic women, an ovarian cystectomy does not significantly degrade fertility outcomes. Patients considering the procedure should however be carefully advised beforehand about how it could potentially impair their ovarian reserve. Alternatively, asymptomatic women who are older and have lower ovarian reserves are more likely to benefit from more conservative treatment strategies. This approach will not hamper their likelihood of having acceptable outcomes, and deleterious effects on their ovaries will be mitigated.
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